Skip to content
City Therapeutics

Senior Director, Corporate Development

Cambridge, Massachusetts, United States; City TherapeuticsUnited States
Director+ · Corporate Development
POSTED 21 OCTVERIFIED 1D AGO
Apply Ask
Role
29 days opentrue age
Posted 21 Oct
Pay
$189k–$258kno pay posted
Market p25–p75
$189k–$258k
Boston · n=389 · 365d to 19 Nov
CompanyCity Therapeutics →
10open roles
Opened · 30d
+2
Closed · 30d
−0
Signal
● Steady+2 net
16d of snapshots · 30d window
Market
25,402open · Director+ Other
Opened · 7d
+2,73711% of open
All other
621,870open
All tracked boards · live 20 Nov · n=25,402

Senior Director, Corporate Development

City Therapeutics is a biotechnology company developing the next generation of RNA interference (RNAi) therapeutics to deliver meaningful and durable benefits for patients. Founded by pioneers in the RNAi field, City combines advanced RNAi trigger engineering with novel targeting technologies to expand the therapeutic potential of RNAi in and beyond the liver. Through its proprietary pipeline and strategic collaborations, City is working to bring innovative medicines to patients with significant unmet medical needs.

City Therapeutics is seeking a strategic and execution-oriented Senior Director of Corporate Development to help shape the company’s long-term growth strategy. Reporting to the Chief Operating Officer, this individual will lead the identification, evaluation, and execution of strategic opportunities that strengthen City’s platform, advance its pipeline, and create sustainable value.

This role will work closely with executive leadership to translate corporate priorities into actionable initiatives, including strategic partnerships, licensing transactions, asset or technology acquisitions, and other growth opportunities. The individual will bring strong scientific and financial judgment, transaction experience, and the ability to build alignment across functions.

The ideal candidate combines strategic perspective with hands-on execution and is comfortable moving between market analysis, financial evaluation, external negotiations, and executive-level recommendations in a growing biotechnology company.

Key Responsibilities

  • Corporate Strategy and Growth Planning: Partner with the COO and executive leadership to develop and execute City’s corporate development strategy.
  • Evaluate opportunities that complement City’s internal capabilities, expand its platform or pipeline, and support long-term corporate objectives.
  • Contribute to strategic planning and portfolio discussions by assessing external opportunities alongside internal investment priorities.
  • Monitor industry trends, competitive developments, and relevant transactions to identify opportunities and inform decision-making.
  • Develop clear strategic recommendations supported by scientific, commercial, financial, and operational analysis.
  • Opportunity Identification and Assessment
  • Build and maintain relationships with biotechnology and pharmaceutical companies, academic institutions, investors, advisors, and other potential strategic partners.
  • Identify and prioritize opportunities for licensing, collaborations, asset or technology acquisitions, and other strategic transactions.
  • Assess opportunities for strategic fit, scientific differentiation, development potential, commercial value, and execution feasibility.
  • Maintain a disciplined opportunity pipeline with clear evaluation criteria, milestones, and recommendations.
  • Coordinate cross-functional diligence across Research, Clinical Development, Regulatory, Finance, Legal, Intellectual Property, and other relevant functions.
  • Partner with Finance to develop valuations, financial models, scenario analyses, and assessments of transaction economics.
  • Evaluate deal structures, investment requirements, risk allocation, and potential returns.
  • Lead or support transactions from initial engagement through diligence, negotiation, definitive agreements, and closing.
  • Collaborate with the COO, Legal, Finance, and other stakeholders to negotiate terms aligned with City’s strategic and financial objectives.
  • Prepare decision materials and presentations for executive leadership and the Board of Directors, as appropriate.
  • Manage transaction timelines, advisors, documentation, and internal communication to support efficient execution.
  • Develop compelling materials that communicate City’s scientific differentiation and strategic value to prospective partners.
  • Represent City in external discussions, partnering meetings, and industry forums.
  • Establish implementation plans for completed transactions, including governance, ownership, milestones, and measures of success.
Source · City TherapeuticsFirst seen 4 NovOriginal ↗